Garonit Pharmaceutical
A Regulatory Affairs Project Lead at Garonit Pharmaceutical drives regulatory strategy and execution for product portfolio advancement, with a focus on ANDA submissions and lifecycle management.
Garonit Pharmaceutical is a US-headquartered (Flanders, NJ) manufacturer and global supplier of active pharmaceutical ingredients, with a primary focus on Chlorhexidine Gluconate 20%. The company is one of the few manufacturers in North America to simultaneously hold US FDA DMF, CEP EDQM, and PMDA Japan DMF certifications for CHG 20%, and operates cGMP facilities in New Jersey and India. Garonit serves 500+ global pharmaceutical clients across six continents, with offices and warehouses spanning North America, Europe, and Asia.
Indian API maker Garonit Pharma plans $46.1M antiseptic product plant in New York
Aug 7, 2025
Garonit Pharmaceutical to build $46.1M plant near Stewart Airport
Aug 7, 2025
Garonit Pharmaceutical to build $46M manufacturing facility in New Windsor
Aug 6, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Garonit Pharmaceutical.
Garonit Pharmaceutical didn’t post a salary, so this is our estimate from similar listings.
$46 million pharmaceutical manufacturing facility announced for Orange County
Aug 4, 2025
Global Pharma Giant Picks Spot Near Stewart Airport For $46M Flagship US Plant
Aug 5, 2025